Skip to main content

User account menu

Show — User account menu Hide — User account menu
  • Log in
Home
Amarin

Amarin Announces Resignation of David Feigal from Board of Directors

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin Announces Resignation of David Feigal from Board of Directors

Amarin Successfully Completes All Remaining Clinical Studies for AMR101 NDA

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin Successfully Completes All Remaining Clinical Studies for AMR101 NDA

Phase 3 ANCHOR and MARINE Trial Data to be Presented in November at the American Heart Association's Scientific Sessions

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Phase 3 ANCHOR and MARINE Trial Data to be Presented in November at the American Heart Association's Scientific Sessions

Amarin Announces Q2, 2011 Results Conference Call

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin Announces Q2, 2011 Results Conference Call

Amarin to Present at the 2011 Canaccord Genuity Growth Conference

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin to Present at the 2011 Canaccord Genuity Growth Conference

Amarin Reports Second Quarter 2011 Results

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin Reports Second Quarter 2011 Results

Amarin Announces Agreement From FDA on Special Protocol Assessment for AMR101 Outcomes Study

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin Announces Agreement From FDA on Special Protocol Assessment for AMR101 Outcomes Study

Amarin to Present at the Wedbush Securities Life Sciences Management Access Conference

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin to Present at the Wedbush Securities Life Sciences Management Access Conference

Data From Amarin's AMR101 Phase 3 MARINE Trial to be Presented at the European Society of Cardiology (ESC) Congress 2011

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Data From Amarin's AMR101 Phase 3 MARINE Trial to be Presented at the European Society of Cardiology (ESC) Congress 2011

Amarin Announces Successful MARINE Phase 3 Clinical Trial Results Published in The American Journal of Cardiology

Submitted by amarin on Fri, 12/08/2017 - 04:48
Home
  • Read more about Amarin Announces Successful MARINE Phase 3 Clinical Trial Results Published in The American Journal of Cardiology

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 212
  • Page 213
  • Page 214
  • Page 215
  • Current page 216
  • Page 217
  • Page 218
  • Page 219
  • Page 220
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Search

API search

Title (indexed field):
Title (indexed field):
Title (indexed field): Home

Footer menu

Show — Footer menu Hide — Footer menu
  • Contact
Powered by Drupal